⌘K
Loading ticker…
PUMA BIOTECHNOLOGY INC · Healthcare · Pharmaceutical Products
As of 2026-06-26, PUMA BIOTECHNOLOGY INC (PBYI) has a 3-month relative strength percentile of 80 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 69. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 4.4%, relative volume 4.42×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 80, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
PBYI is in a stage 2 uptrend, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 11.3% / 30.7%.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
PBYI is held by 3 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $9M notional. Top 3 carry $18M.
Top 3 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $9M |
| IWMiShares Russell 2000 ETF | 0.01% | $7M |
| VXFVanguard Extended Market ETF | 0.00% | $3M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PBYI Jan avg: 3.46% median: 5.10% win: 75% σ: 6.70% n: 4 2022-04-12 → 2026-05-29 | PBYI Feb avg: 8.49% median: 6.82% win: 50% σ: 22.93% n: 4 2022-04-12 → 2026-05-29 | PBYI Mar avg: -9.99% median: -16.05% win: 25% σ: 14.88% n: 4 2022-04-12 → 2026-05-29 | PBYI Apr avg: -1.85% median: -4.34% win: 40% σ: 14.28% n: 5 2022-04-12 → 2026-05-29 | PBYI May avg: -3.65% median: -4.53% win: 40% σ: 19.27% n: 5 2022-04-12 → 2026-05-29 | PBYI Jun avg: 10.38% median: 4.97% win: 75% σ: 26.16% n: 4 2022-04-12 → 2026-05-29 (current) | PBYI Jul avg: 1.50% median: 2.68% win: 75% σ: 8.00% n: 4 2022-04-12 → 2026-05-29 | PBYI Aug avg: 5.88% median: -4.13% win: 50% σ: 39.59% n: 4 2022-04-12 → 2026-05-29 | PBYI Sep avg: -7.94% median: -4.78% win: 50% σ: 14.98% n: 4 2022-04-12 → 2026-05-29 | PBYI Oct avg: -1.67% median: -5.21% win: 25% σ: 9.11% n: 4 2022-04-12 → 2026-05-29 | PBYI Nov avg: 45.96% median: 38.74% win: 75% σ: 47.82% n: 4 2022-04-12 → 2026-05-29 | PBYI Dec avg: 3.10% median: 2.31% win: 50% σ: 13.45% n: 4 2022-04-12 → 2026-05-29 |